Biosimulation Market

  • Published on 2025-11-19
  • Report Code: 2224
  • 170 - 350 pages
Biosimulation Market

Biosimulation Market Size, Share, and Analysis, By Product (Software, Services), By Application (Drug Discovery, Disease Modelling, and Others), By Therapeutic Area (Oncology, Cardiovascular Disease, Infectious Disease, Neurological Disorders, and Others), By Deployment Mode (Cloud-based, On-premise, and Hybrid Model), By Pricing Model (License-based Model, Subscription-based Model, Service-based Model, Pay Per Use Model), By End User (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, Regulatory Authorities, and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

Table Of Content

  1. Executive Summary
    • Regional Market Share
    • Business Trends
    • Biosimulation Market: COVID-19 Outbreak
    • Regional Trends
    • Segmentation Snapshot
  2. Research Methodology
    • Research Objective
    • Research Approach
    • Data Sourcing and Methodology
    • Primary Research
    • Secondary Research
      • Paid Sources
      • Public Sources     
    • Market Size Estimation and Data Triangulation
  3. Market Characteristics
    • Market Definition
    • Biosimulation Market: COVID-19 Impact
    • Key Segmentations
    • Key Developments
    • Allied Industry Data
  4. Biosimulation Market – Industry Insights
    • Industry Segmentation
    • COVID-19 overview on world economy
    • Industry ecosystem Channel analysis
    • Innovation & Sustainability
  5. Macroeconomic Indicators
  6. Recent Developments
  7. Market Dynamics
    • Introduction
    • Growth Drivers
    • Market Opportunities
    • Market Restraints
    • Market Trends
  8. Risk Analysis
  9. Market Analysis
    • Porters Five Forces
    • PEST Analysis
      • Political
      • Economic
      • Social
      • Technological
  1. Biosimulation Market
    • Overview
    • Historical Analysis (2019-2022)
      • Market Size, Y-o-Y Growth (%) and Market Forecast
  1. Biosimulation Market Size & Forecast 2024A-2034F
    • Overview
    • Key Findings
    • Market Segmentation
      • By Product
        • Software
          • By Value (USD Million) 2024-2034F
          • Market Share (%) 2024-2034F
          • Y-o-Y Growth (%) 2024-2034F
        • Services
          • By Value (USD Million) 2024-2034F
          • Market Share (%) 2024-2034F
          • Y-o-Y Growth (%) 2024-2034F
        • By Application
          • Drug Discovery
            • By Value (USD Million) 2024-2034F
            • Market Share (%) 2024-2034F
            • Y-o-Y Growth (%) 2024-2034F
          • Disease Modelling
            • By Value (USD Million) 2024-2034F
            • Market Share (%) 2024-2034F
            • Y-o-Y Growth (%) 2024-2034F
          • Others
            • By Value (USD Million) 2024-2034F
            • Market Share (%) 2024-2034F
            • Y-o-Y Growth (%) 2024-2034F
          • By Therapeutic Area
            • Oncology
              • By Value (USD Million) 2024-2034F
              • Market Share (%) 2024-2034F
              • Y-o-Y Growth (%) 2024-2034F
            • Cardiovascular Disease
              • By Value (USD Million) 2024-2034F
              • Market Share (%) 2024-2034F
              • Y-o-Y Growth (%) 2024-2034F
            • Infectious Disease
              • By Value (USD Million) 2024-2034F
              • Market Share (%) 2024-2034F
              • Y-o-Y Growth (%) 2024-2034F
            • Neurological Disorders
              • By Value (USD Million) 2024-2034F
              • Market Share (%) 2024-2034F
              • Y-o-Y Growth (%) 2024-2034F
            • Others
              • By Value (USD Million) 2024-2034F
              • Market Share (%) 2024-2034F
              • Y-o-Y Growth (%) 2024-2034F
            • By Deployment Mode
              • Cloud-based
                • By Value (USD Million) 2024-2034F
                • Market Share (%) 2024-2034F
                • Y-o-Y Growth (%) 2024-2034F
              • On-Premise
                • By Value (USD Million) 2024-2034F
                • Market Share (%) 2024-2034F
                • Y-o-Y Growth (%) 2024-2034F
              • Hybrid Model
                • By Value (USD Million) 2024-2034F
                • Market Share (%) 2024-2034F
                • Y-o-Y Growth (%) 2024-2034F
              • By Pricing Model
                • License-based Model
                  • By Value (USD Million) 2024-2034F
                  • Market Share (%) 2024-2034F
                  • Y-o-Y Growth (%) 2024-2034F
                • Subscription-based Model
                  • By Value (USD Million) 2024-2034F
                  • Market Share (%) 2024-2034F
                  • Y-o-Y Growth (%) 2024-2034F
                • Hybrid Model
                  • By Value (USD Million) 2024-2034F
                  • Market Share (%) 2024-2034F
                  • Y-o-Y Growth (%) 2024-2034F
                • By End User
                  • Contact Research Organizations
                    • By Value (USD Million) 2024-2034F
                    • Market Share (%) 2024-2034F
                    • Y-o-Y Growth (%) 2024-2034F
                  • Pharmaceutical & Biotechnology Companies
                    • By Value (USD Million) 2024-2034F
                    • Market Share (%) 2024-2034F
                    • Y-o-Y Growth (%) 2024-2034F
                  • Regulatory Authorities
                    • By Value (USD Million) 2024-2034F
                    • Market Share (%) 2024-2034F
                    • Y-o-Y Growth (%) 2024-2034F
                  • Academic Research Insitutues
                    • By Value (USD Million) 2024-2034F
                    • Market Share (%) 2024-2034F
                    • Y-o-Y Growth (%) 2024-2034F
  1. North America Biosimulation Market Size & Forecast 2024A-2034F
    • Overview
    • Key Findings
    • Market Segmentation
      • By Product
      • By Application
      • By Deployment Mode
      • By Pricing Model
      • By End User
    • Country
      • United States
      • Canada
  1. Europe Biosimulation Market Size & Forecast 2024A-2034F
    • Overview
    • Key Findings
    • Market Segmentation
      • By Product
      • By Application
      • By Deployment Mode
      • By Pricing Model
      • By End User
    • Country
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
  1. Asia-Pacific Biosimulation Market Size & Forecast 2024A-2034F
    • Overview
    • Key Findings
    • Market Segmentation
      • By Product
      • By Application
      • By Deployment Mode
      • By Pricing Model
      • By End User
    • Country
      • India
      • China
      • South Korea
      • Japan
      • Rest of APAC
  1. Middle East and Africa Biosimulation Market Size & Forecast 2024A-2034F
    • Overview
    • Key Findings
    • Market Segmentation
      • By Product
      • By Application
      • By Deployment Mode
      • By Pricing Model
      • By End User
    • Country
      • Israel
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East and Africa
  1. Latin America Biosimulation Market Size & Forecast 2024A-2034F
    • Overview
    • Key Findings
    • Market Segmentation
      • By Product
      • By Application
      • By Deployment Mode
      • By Pricing Model
      • By End User
    • Country
      • Mexico
      • Brazil
      • Rest of Latin America
  1. Competitive Landscape
    • Company market share, 2023
    • Key player overview
    • Key stakeholders
  2. Company Profiles
    • Certara, Inc.
      • Company Overview
      • Financial Overview
      • Key Product; Analysis
      • Company Assessment
        • Product Portfolio
        • Key Clients
        • Market Share
        • Recent News & Development (Last 3 Yrs.)
        • Executive Team
      • Simulation Plus, Inc.
      • Schrödinger, Inc.
      • Dassault Systèmes
      • Advanced Chemistry Development (ACD/Labs)
      • Rosa & Co. LLC
      • Chemical Computing Group ULC
      • Genedata AG
      • Insilico Biotechnology AG
      • Evidera, Inc.
      • Leadscope, Inc.
      • BioSimulation Consulting Inc.
      • Nuventra Pharma Sciences
      • CertusBio
      • Physiomics PLC
      • Other Prominent Players
  1. Appendix

Consultant Recommendation

 
To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients